Page last updated: 2024-08-24

rhodamine 123 and Adenocarcinoma Of Kidney

rhodamine 123 has been researched along with Adenocarcinoma Of Kidney in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alzpodien, J; Anastassiou, G; Brevis Nunez, F; Buer, J; Duensing, S; Ganser, A; Grosse, J; Meyer, N; Nasarek, A; Probst, M1
Anttila, M; Braybrooke, JP; Ellmén, J; Ganesan, TS; Harris, AL; Houlbrook, S; Rockett, H; Talbot, DC; Vallis, KA1

Trials

1 trial(s) available for rhodamine 123 and Adenocarcinoma Of Kidney

ArticleYear
Evaluation of toremifene for reversal of multidrug resistance in renal cell cancer patients treated with vinblastine.
    Cancer chemotherapy and pharmacology, 2000, Volume: 46, Issue:1

    Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug Administration Schedule; Drug Resistance, Multiple; Female; Fluorescent Dyes; Humans; Kidney Neoplasms; Male; Middle Aged; Orosomucoid; Protein Binding; Rhodamine 123; Tamoxifen; Toremifene; Vinblastine

2000

Other Studies

1 other study(ies) available for rhodamine 123 and Adenocarcinoma Of Kidney

ArticleYear
Exposure to vinblastine modulates beta 1 integrin expression and in vitro binding to extracellular matrix molecules in a human renal carcinoma cell line.
    Invasion & metastasis, 1996, Volume: 16, Issue:2

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Renal Cell; Cell Adhesion; Drug Resistance, Neoplasm; Extracellular Matrix Proteins; Gene Expression Regulation, Neoplastic; Humans; Integrin beta1; Kidney Neoplasms; Neoplasm Proteins; Receptors, Very Late Antigen; Rhodamine 123; Rhodamines; Tumor Cells, Cultured; Vinblastine

1996